343 related articles for article (PubMed ID: 34670595)
1. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
Deng J
J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
Weatherald J; Boucly A; Savale L; Jaïs X; Montani D; Humbert M; Sitbon O
Am J Respir Crit Care Med; 2021 Feb; 203(4):524-525. PubMed ID: 33105080
[No Abstract] [Full Text] [Related]
3. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
Maron BA; Humbert M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
[No Abstract] [Full Text] [Related]
4. Reply to Weatherald
Badagliacca R; D'Alto M; Ghio S; Vizza CD; Naeije R
Am J Respir Crit Care Med; 2021 Feb; 203(4):525-526. PubMed ID: 33105086
[No Abstract] [Full Text] [Related]
5. Pulmonary arterial hypertension: the clinical syndrome.
Lai YC; Potoka KC; Champion HC; Mora AL; Gladwin MT
Circ Res; 2014 Jun; 115(1):115-30. PubMed ID: 24951762
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
Guo X; Lai J; Wang H; Tian Z; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
Hypertension; 2020 Oct; 76(4):1161-1168. PubMed ID: 32772648
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways in Pulmonary Arterial Hypertension.
Shah AJ; Vorla M; Kalra DK
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077398
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
9. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
[TBL] [Abstract][Full Text] [Related]
10. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.
MacKenzie Ross RV; Toshner MR; Soon E; Naeije R; Pepke-Zaba J
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H259-64. PubMed ID: 23686712
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic Thresholds for Precapillary Pulmonary Hypertension.
Gerges C; Gerges M; Skoro-Sajer N; Zhou Y; Zhang L; Sadushi-Kolici R; Jakowitsch J; Lang MB; Lang IM
Chest; 2016 Apr; 149(4):1061-73. PubMed ID: 26501411
[TBL] [Abstract][Full Text] [Related]
12. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
13. The Pathobiology of Pulmonary Arterial Hypertension.
Rajagopal S; Yu YA
Cardiol Clin; 2022 Feb; 40(1):1-12. PubMed ID: 34809910
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-associated pulmonary arterial hypertension.
Barnett CF; Hsue PY
Clin Chest Med; 2013 Jun; 34(2):283-92. PubMed ID: 23702177
[TBL] [Abstract][Full Text] [Related]
15. The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.
Badagliacca R; Papa S; Matsubara H; Lang IM; Poscia R; Manzi G; Vizza CD
Int J Cardiol; 2020 Feb; 301():183-189. PubMed ID: 31806280
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of pulmonary arterial hypertension.
Beshay S; Sahay S; Humbert M
Respir Med; 2020 Sep; 171():106099. PubMed ID: 32829182
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of the clinical functional and hemodynamic profile of patients with pulmonary arterial hypertension with initial monotherapy with endothelin receptor antagonists: bosentan vs. macitentan].
Martynyuk TV; Aleevskaya AM
Kardiologiia; 2020 Aug; 60(7):28-35. PubMed ID: 33155938
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
Takatsuki S; Wagner BD; Ivy DD
Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-associated pulmonary arterial hypertension.
Kolaitis NA; Saggar R; De Marco T
Curr Opin Pulm Med; 2022 Sep; 28(5):352-360. PubMed ID: 35838374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
